Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masaru Matsumoto is active.

Publication


Featured researches published by Masaru Matsumoto.


Diseases of The Colon & Rectum | 1999

Ratio of primary and secondary bile acids in feces

Toshiki Kamano; Yoshi Mikami; Tsuneo Kurasawa; Masahiko Tsurumaru; Masaru Matsumoto; Motonari Kano; Koki Motegi

PURPOSE: Increases in fecal bile acids may play a role in colorectal carcinogenesis. The authors tested the hypothesis that high concentrations of primary and secondary bile acids are more common in patients with colon cancer than in patients with other gastrointestinal diseases. METHODS: In this retrospective study the secondary bile acid deoxycholic acid and the primary bile acid cholic acid were measured in the feces by enzyme-linked immunoabsorbent assay in 63 patients with colorectal cancer, 24 patients with gastric cancer, 11 patients with biliary disorders, and 47 healthy volunteers. RESULTS: Preoperatively, the mean deoxycholic acid values tended to be higher and the cholic acid values were significantly lower in patients with colorectal cancer than in healthy subjects. Patients with other gastrointestinal diseases had lower deoxycholic acid and cholic acid values than healthy subjects. In healthy subjects the deoxycholic acid to cholic acid ratio ranged from 0.10 to 2.86 (mean, 0.88), but in almost two-thirds, the ratio did not exceed 1. In contrast, the mean preoperative ratio in patients with colorectal cancer was 2.26 (range, 0.06–7.17;P<0.0001) and tended to be higher in patients with advanced cancer and in those with sigmoid and rectal tumors. If 1.1 is taken as the upper limit of normal for deoxycholic acid to cholic acid ratio, 67 percent of patients with colorectal cancer had an abnormal value preoperatively. CONCLUSION: A high deoxycholic acid concentration and deoxycholic acid to cholic acid ratio may be indicators of colorectal cancer. Further study is needed to improve sensitivity and specificity, perhaps by combining fecal bile acid measurements with other tests, and a large prospective trial may be warranted to determine whether these measurements have value in screening for this common cancer.


Current Therapeutic Research-clinical and Experimental | 1994

DIAGNOSTIC SIGNIFICANCE OF MEASUREMENT OF FECAL BILE ACIDS IN COLORECTAL CANCER PATIENTS

Toshiki Kamano; Masaru Matsumoto; Motonari Kano

Fecal bile acid values in 23 patients with colorectal cancer were shown to have diagnostic significance. Deoxycholic acid (DCA) and cholic acid (CA) were measured using the enzyme-linked immunosorbent assay method and the DCA:CA ratio was used for the pre- and postoperative comparison. The postoperative ratio was found to be lower than the preoperative ratio in every patient. This finding indicates the clinical usefulness of the DCA:CA ratio in monitoring the progress of colorectal cancer. This type of monitoring may be useful for screening patients for colorectal cancer in high-risk populations.


Archive | 1993

Significance of Fecal Bile Acid Ratio in Colorectal Cancer Patients

Toshiki Kamano; Kei Nakamura; Youshi Mikami; Noburu Sakakibara; Motonari Kano; Masaru Matsumoto

Fecal bile acid values in 10 colorectal cancer patients have been demonstrated to have diagnostic significance. Deoxycholic acid (DCA) and cholic acid (CA) were measured by Emzyme Linked Immunosorbent Assay (ELISA) method and their composition ratio (DCA/CA) was used for the pre and post operative comparison. The post operative ratio was found to be lower than the pre operative ratio in every patient. The result can be anticipated the clinical utility in the diagnosis of colorectal cancer patients.


Diseases of The Colon & Rectum | 1999

Ratio of primary and secondary bile acids in feces: possible marker for colorectal cancer?

Toshiki Kamano; Yoshi Mikami; Tsuneo Kurasawa; Masahiko Tsurumaru; Masaru Matsumoto; Motonari Kano; Koki Motegi


The Japanese journal of clinical pathology | 2006

Studies of serum and feces bile acids determination by gas chromatography-mass spectrometry.

Tomoaki Tadano; Motonari Kanoh; Masaru Matsumoto; Kazuhiro Sakamoto; Toshiki Kamano


The Japanese journal of clinical pathology | 2007

Kinetic analysis of bile acids in the feces of colorectal cancer patients by gas chromatography-mass spectrometry (GC-MS).

Tomoaki Tadano; Motonari Kanoh; Hiroshi Kondoh; Masaru Matsumoto; Kunihiro Mimura; Yuhsaku Kanoh; Kazuhiro Sakamoto; Toshiki Kamano


The Japanese journal of clinical pathology | 2004

Development of an enzyme-linked immunosorbent assay for fecal bile acid.

Masaru Matsumoto; Hajime Takei; Motonari Kanoh; Toshiki Kamano; Masako Maeda


Archive | 1995

Method for the measurement of serum bile acids by elisa and method for the diagnosis of liver disease

Motonari Kano; Masaru Matsumoto


Archive | 1994

Anti-bile acid antibodies and method for assaying bile acids in feces by using the same

Motonari Kano; Masaru Matsumoto; Hiroshi Wada; Koki Motegi


The Showa University Journal of Medical Sciences | 1993

Human Fecal Bile Acids and Frations with Enzyme-Linked Immunosorbent Assay

Motonari Kano; Hiroshi Wada; Masaru Matsumoto; Kenji Yamamoto; Toshiki Kamano; Koki Motegi; Katsuji Oguchi; Yusaku Kano

Collaboration


Dive into the Masaru Matsumoto's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge